Body Fluid Or Exudate Or Transudate Other Than Snake Venom, Feces, Urine, Or Semen (e.g., Lymph, Saliva, Honey, Royal Jelly, Digestive Juice, Etc.) Patents (Class 424/537)
-
Publication number: 20120076867Abstract: A substantially non-aqueous, aerated composition is free of petroleum-based components and is suitable for skin applications, The composition primarily includes wax and oil, and can further include vitamin E oil and an essential oil. The composition can be a semi-solid at room temperature. A method of making the composition includes melting together component ingredients to form a mixture, which is then cooled to form hardened matter. The hardened matter is blended to form a flowable mixture, which is then forced through a sieve to form the aerated composition.Type: ApplicationFiled: March 31, 2011Publication date: March 29, 2012Applicant: Waxelene, Inc.Inventors: Chris Ejyo Remington, Todd Stuart Cooper
-
Publication number: 20120052131Abstract: The present invention is in the fields of medicine, pharmaceuticals, neutraceuticals and rheumatology. The invention provides pharmaceutical compositions for the treatment and/or prevention of osteoarthritis in mammals, particularly humans, comprising sodium bicarbonate and calcium gluconate, and optionally comprising one or more additional components. The invention also provides methods of treating or preventing osteoarthritis by administering to a mammal, preferably via intraarticular injection, one or more compositions of the invention.Type: ApplicationFiled: September 16, 2011Publication date: March 1, 2012Inventors: Ricardo AMADOR, Jorge L. Rosado, Sandra García-Padilla, Miguel Ángel Duarte-vázquez
-
Publication number: 20120034309Abstract: The present application relates to a honey product having a low water content. The honey product retains the physical and palatable properties of untreated honey while having a prolonged shelf-life. It can be advantageously used to sweeten beverages (such as hot beverages) and in the manufacture of throat lozenges and/or confectionery.Type: ApplicationFiled: January 15, 2010Publication date: February 9, 2012Inventor: John L. Rowe
-
Publication number: 20120034310Abstract: A composition comprising vegetable/herbal based dietary ingredients, or extracts, which contains vitamins and nutrients that provide a novel nontoxic treatment for liver cancers, hepatitis, and liver cirrhosis. The composition can be taken as a daily dietary supplement to enhance normal physiological functions of the body. The said composition, or extracts thereof, are useful and effective in the treatment and prevention of liver and possibly other cancers. The compositions are also useful for administration to patients with pre-existing hepatitis and/or liver cirrhosis. The compositions or extracts thereof may be useful for treating other cancers and other disorders, diseases, or conditions.Type: ApplicationFiled: August 1, 2011Publication date: February 9, 2012Applicant: Canthao CorporationInventors: Can V. Bui, Cuong Q. Bui
-
Publication number: 20120027868Abstract: An improved topical cosmetic skin formulation is provided. The inventive formulation includes leaf lard as a base, zinc oxide and beeswax. In addition, slippery elm bark may be added to the formulation. Further, benzoin styrax may be added to the inventive formulation.Type: ApplicationFiled: August 2, 2010Publication date: February 2, 2012Inventor: Donna Penney
-
Publication number: 20120021061Abstract: Compositions, methods of production and uses are described to maintain or increase the medical and/or nutritional potency of honey or honey analogues primarily by manipulating or fortifying the phenolic content of the honey or honey analogue in the composition.Type: ApplicationFiled: December 23, 2009Publication date: January 26, 2012Applicant: Comvita New Zealand LimitedInventors: Ralf-Christian Schlothauer, Jonathan McDonald Counseil Stephens
-
Publication number: 20120021060Abstract: A composition for treating or alleviating the symptoms of sinusitis comprising Manuka honey at a concentration of from about 0.5% v/v to about 7% v/v in an aqueous pH-balanced solution is provided. In one embodiment, the concentration of Manuka honey is from about 3% v/v to about 6% v/v. In another embodiment, the concentration of Manuka honey is from about 4% v/v to about 5% v/v. A method of treating or alleviating the symptoms of sinusitis in a patient in need of such treatment, where the method comprises intranasally administrating the above composition to such patient in order to treat the sinusitis, is provided. A further method of improving olfactory function in a patient in need of treatment is provided, where the method comprises intranasally administering the above composition to such patient in order to improve olfactory function.Type: ApplicationFiled: July 21, 2010Publication date: January 26, 2012Inventors: Amin Ramzanali Javer, Ezra Kwok
-
Publication number: 20120015041Abstract: This invention is disclosing a pure ointment of traditional Chinese medicine which was invented to treat burn or scald, and infectious trauma, and its preparation. The ointment has solved a number of problems in the treatment of burn or scald, and infectious trauma, such as the high cost of current drugs, post-treatment scar, and unfavorable therapeutic effect. The advantages of this ointment include low cost, favorable therapeutic effect, short course, and without scar after treatment. Its formula is based on the weight of every five hundred portions of following ingredients: lithospermum, 4-10 portions, beeswax, 5-20 potions, insect-white wax, 5-20 portions, and lard, 450-486 portions.Type: ApplicationFiled: March 4, 2010Publication date: January 19, 2012Inventor: Xinwei Sun
-
Patent number: 8097284Abstract: Various embodiments of this invention disclose a polarized dilute blue scorpion venom solution, a method for making a polarized dilute scorpion venom solution, and a method for administering dilute scorpion venom solution. The polarized dilute scorpion venom solution relieves pain, improves immune-system response, treats cancer, prevents cancer, improves quality of sleep, reduces inflammation, and minimizes negative biological response to chemotherapy and radiation treatment.Type: GrantFiled: November 13, 2008Date of Patent: January 17, 2012Inventor: Arthur Mikaelian
-
Publication number: 20110311641Abstract: The present invention provides a pharmaceutical composition for dehydrating and atrophying pathological tissues comprising ferric subsulfate, polyferric sulfate or a mixture thereof is disclosed. Ferric subsulfate and polyferric sulfate are traditionally used as water treatment agent. The inventor surprisingly discovered the medical value of these substances. The compositions are cost-effective, convenient to use and have significant effects in treatment of vascular diseases such as hemorrhoids, hemangiomas, hematomas (including hematomas caused by brain hemorrhage), thrombi and varices, and topical traumas such as bleeding and edemas. The compositions are also capable of killing various tumor cells by targeted injection.Type: ApplicationFiled: August 24, 2009Publication date: December 22, 2011Inventors: Kuok Leong Tam, Io cheng Tam, Hio man Tam
-
Publication number: 20110311640Abstract: A skin care composition comprising an isolated Asteroidea body fluid or extract thereof is described. Uses and methods of use of the composition for the prevention and/or treatment of a skin disorder or condition, such as skin-aging signs, are also described.Type: ApplicationFiled: June 23, 2009Publication date: December 22, 2011Applicant: Innovactiv Inc.Inventors: Martin Beaulieu, Estelle Loing, Catherine Fillion, Patrice Dionne, Alain Lavoie, Alain Thibodeau
-
Publication number: 20110287106Abstract: A cognitive impairment ameliorant is provided that is useful for the prevention or treatment of cognitive impairment, and particularly Alzheimer's disease. The cognitive impairment ameliorant contains royal jelly as an active ingredient thereof.Type: ApplicationFiled: June 16, 2009Publication date: November 24, 2011Inventors: Kikuji Yamaguchi, Yasushi Ohizumi, Tohru Yamakuni, Akira Nakajima, Yoshiharu Iwabuchi, Masatoshi Shibuya
-
Publication number: 20110287059Abstract: A number of methods of analysing honey are described to determine the age of the honey, the presence of fortification with additives including methylglyoxal (MGO), the region from which the honey is derived, the plant species from which the honey is derived and whether the honey has been heated during processing. The various characteristics are determined based on the phenolic concentrations in the honey which have been found to provide very clear markers for the above characteristics. The methods of analysis described have many applications, particularly around quality assurance and ensuring that honeys are true to labeled specifications.Type: ApplicationFiled: December 23, 2009Publication date: November 24, 2011Applicant: COMVITA NEW ZEALAND LIMITEDInventors: Jonathan Counsell Stephens, Ralf-Christian Schlothauer
-
Publication number: 20110268812Abstract: A cosmetic composition has a combination of honey or royal jelly, and a peptide, including at least the amino acid sequence Gly-X1-X2-Pro-Gly. Applying the composition makes it possible to delay the appearance of the signs of skin aging or to slow down the effects thereof.Type: ApplicationFiled: February 25, 2011Publication date: November 3, 2011Applicant: LVMH RECHERCHEInventors: Jean-Hubert Cauchard, Frëdëric Bonte, Emmanuelle Noblesse, Carine Nizard
-
Publication number: 20110262551Abstract: A cosmetic composition includes, as a cosmetic active agent, a honey from clover (Trifolium repens) or an extract of this honey. A method uses a cosmetic composition, of a honey from clover (Trifolium repens), or an extract of this honey, as an active agent for preventing or delaying the appearance of the signs of aging of the skin or slowing the effects thereof, in particular for restructuring the epidermis, toning the skin and/or promoting the attenuation or resorption of wrinkles or lines, notably on the face and neck. A method of cosmetic care also uses this cosmetic composition.Type: ApplicationFiled: February 1, 2011Publication date: October 27, 2011Applicant: LVMH RECHERCHEInventors: Carine NIZARD, Jean-Hubert CAUCHARD, Kristell LAZOU, Jean-Christophe ARCHAMBAULT, Emmanuelle NOBLESSE, Frédéric BONTE, Sylvianne SCHNEBERT, Eric PERRIER
-
Patent number: 8012510Abstract: A composition comprising vegetable/herbal-based dietary ingredients, or extracts, which contains vitamins and nutrients that provide a novel nontoxic treatment for liver cancers, hepatitis, and liver cirrhosis. The composition can be taken as a daily dietary supplement to enhance normal physiological functions of the body. The said composition, or extracts thereof, are useful and effective in the treatment and prevention of liver and possibly other cancers. The compositions are also useful for administration to patients with pre-existing hepatitis and/or liver cirrhosis. The compositions or extracts thereof may be useful for treating other cancers and other disorders, diseases, or conditions.Type: GrantFiled: June 10, 2004Date of Patent: September 6, 2011Assignee: Canthao CorporationInventors: Can V. Bui, Cuong Q. Bui, legal representative
-
Publication number: 20110212184Abstract: An ultra fine mineral compound and method of processing native Dead Sea minerals into this ultra fine mineral compound that can be used to manufacture all natural Dead Sea mineral compositions particularly compositions for use in bath and body products is disclosed. Even with the extreme ionic character of the Dead Sea minerals, the Dead Sea mineral compositions prepared remain in suspension creating a viable cosmetic preparation that can maintain adequate shelf life and provide a more pleasant feel for the consumer.Type: ApplicationFiled: May 6, 2011Publication date: September 1, 2011Inventors: Morris Samelson, Johnathan M. Scharff
-
Publication number: 20110171283Abstract: The present invention relates to a composition containing at least one nutritive, at least one disinfecting or decontaminating and/or at least one protease-inhibiting active compound and/or active compound complex for the external care and/or treatment of wounds of the human or animal body.Type: ApplicationFiled: July 1, 2008Publication date: July 14, 2011Inventor: Birgit Riesinger
-
Publication number: 20110158932Abstract: Methods and compositions containing a berberine compound or berberine related or derivative compound are provided for the prevention and treatment of hyperlipidemia, elevated cholesterol, and/or cardiovascular disease in mammalian subjects. The methods and compositions of the invention are effective for prevention and treatment of atherosclerosis, coronary artery disease, angina pectoris, carotid artery disease, stroke, cerebral arteriosclerosis, high blood pressure, myocardial infarction, cerebral infarction, restenosis following balloon angioplasty, intermittent claudication, dyslipidemia post-prandial lipidemia or xanthoma.Type: ApplicationFiled: December 8, 2008Publication date: June 30, 2011Inventors: Jian-Dong Jiang, Jing Wei, Wei-Jia Kong, Li-Xun Zhao, Dan-Qing Song
-
Publication number: 20110159104Abstract: The present invention relates to biocompatible microemulsions based on honey which can additionally comprise both water-soluble and also fat-soluble active ingredients in stable form. Via the microemulsion bioavailable nutrients bonded in the honey, preferably together with further active substances, are introduced by topical application into the skin or orally, nasally or percutaneously into the body where they develop their positive effects. These emulsions can be prepared easily and are used both in medicine/veterinary medicine, dermatology and also in cosmetics. Moreover, the honey microemulsions can be used on their own or with nutritionally relevant substances in the fields of foodstuff, functional foods, food supplements or dietetic products.Type: ApplicationFiled: July 22, 2009Publication date: June 30, 2011Inventor: Alexander Teslenko
-
Publication number: 20110142954Abstract: A topical treatment for psoriasis, eczema and other disorders and conditions includes beeswax, coconut oil, shea butter and cocoa butter. Optional ingredients can also be included. A method of manufacturing the composition includes the steps of preheating and liquifying the beeswax, adding other ingredients, slowly stirring the resulting composition at an elevated temperature, and formulating finished treatment products, such as bars and lotions.Type: ApplicationFiled: February 23, 2011Publication date: June 16, 2011Inventors: Teri L. Koelzer, William J. Koelzer
-
Publication number: 20110142955Abstract: The present invention relates to an agent for ameliorating stress-induced immune function modulation which comprises royal jelly. In addition, the present invention provides an anti-stress agent, pharmaceutical, food or beverage, or food additive that contains royal jelly as an active ingredient thereof and prevents or alleviates various somatic symptoms caused by stress.Type: ApplicationFiled: July 15, 2009Publication date: June 16, 2011Applicants: UNIVERSITY OF THE RYUKYUSInventors: Yoshiya Sato, Kaiissar Mannoor, Hisami Watanabe, Kikuji Yamaguchi, Mayu Tsukamoto
-
Publication number: 20110135746Abstract: Lip balm formulations are disclosed that comprise a combination of anti-bacterial, anti-viral, and anti-fungal substances, including: bees wax, cocoa butter, Shea butter, Jojoba oil, Naroli oil, myrrh, tea tree oil, lavender oil, Blue Moroccan chamomile, and vitamin E and, optionally, Manuca honey and aloe vera either singularly or together with the other ingredients.Type: ApplicationFiled: December 9, 2009Publication date: June 9, 2011Inventors: Janice L. Triplett, David C. Triplett, JR.
-
Publication number: 20110123581Abstract: A soft capsule capable being substantially free of or having a minimum content of a fat and oil material and an emulsifier in an encapsulated liquid or medicinal liquid. The soft capsule contains a dietary fiber in an amount of 5 to 90% by weight based on a whole composition of the medicinal liquid.Type: ApplicationFiled: January 27, 2011Publication date: May 26, 2011Inventors: Toshimitsu Ishikawa, Nobuyuki Wada, Futao Kawaguchi, Koji Kajima
-
Publication number: 20110104279Abstract: A method for treating wounds, comprising providing a dry powder mixture, which when partially hydrated, forms a gel having an osmotic pressure sufficient to achieve and maintain antiseptic conditions in hydrated portions of the gel, the gelled portion comprising a biocompatible polymer, the dry powder being readily wettable by wound secretions; and applying the dry powder to a wound having wound secretions in sufficient excess to produce a self-adherent gel cake having a dry powder surface. The administration may be repeated by administration of the dry powder while wound healing progresses.Type: ApplicationFiled: November 4, 2009Publication date: May 5, 2011Inventors: Philip A. Marraccini, Maria Dioguardi
-
Patent number: 7927630Abstract: A method of using fluid aspirates as vehicles for drug delivery by collecting a fluid aspirate such as synovial joint effusion, pleural effusion, pericardial effusion, or ascites from a patient and centrifuging the fluid aspirate to provide a supernatant and a sedimented material. The sedimented material can optionally be further purified. One or more factors such as cytokines, bone morphogenetic proteins (BMPs), pharmaceutical drugs and gene vectors are added to the sedimented material or supernatant, optionally also including a biologically compatible medium such as a bioabsorbable sponge, so as to provide a vehicle for the one or more factors for reintroducion into the patient.Type: GrantFiled: September 11, 2006Date of Patent: April 19, 2011Inventor: Lanny L. Johnson
-
Patent number: 7919126Abstract: Disclosed is an effervescent composition that includes a viscous component is in the form of a free flowing granulation, a tablet made from the free flowing granulation, and a method of using the effervescent composition.Type: GrantFiled: December 8, 2008Date of Patent: April 5, 2011Assignee: Amerilab Technologies, Inc.Inventors: Mary Aldritt, Fred Wehling, Robert E. Lee
-
Patent number: 7919123Abstract: The present invention provides novel compositions and methods for repair and regeneration of tissues or organs of the body, especially mucosa in the gastrointestinal tract. The composition can be used as a pharmaceutical or nutraceutical to treat or prevent gastrointestinal cancer such as colorectal carcinoma, stomach cancer and esophagus cancer. The composition is in an oral dosage form and comprises edible oil homogenized with a sterol compound at a concentration of at least 0.5% by weight and edible wax at a concentration ranging from 3% to 30% by weight.Type: GrantFiled: December 6, 2007Date of Patent: April 5, 2011Inventor: Rongxiang Xu
-
Publication number: 20110038945Abstract: The present invention is a medicament, which is orally ingested by a living human subject for the prophylactic or therapeutic treatment of a heartburn inducing event or an acid reflux episode (GERD). In the preferred embodiments, the complete medicament is a fluid blending of at least one concentrated vinegar made by the fermentation of a fruit or fruit sugar, or a vegetable carbohydrate or sugar, or a grain carbohydrate or sugar; an undiluted bioactive honey having unique, non-peroxide antibacterial activity; a natural flavoring agent or combination of different natural flavors to neutralize the taste of the concentrated vinegar; and a natural sweetener to give the fluid blending a palatable taste. In these formulations, the concentrated vinegar serves to treats the symptoms of the heartburn and/GERD; and the undiluted bioactive honey employs its non-peroxide antibacterial activity to treat inflammation of the esophagus and infections of the stomach.Type: ApplicationFiled: August 13, 2009Publication date: February 17, 2011Inventor: Gavin M. Gear
-
Publication number: 20110033555Abstract: The present invention relates to a method of producing wax/oil-in-water (O/W) dispersions of self-emulsifying O/W gel concentrates without stirring or in a laminar flow field.Type: ApplicationFiled: December 19, 2008Publication date: February 10, 2011Inventors: Klaus Kwetkat, Ursula Michel
-
Publication number: 20110020462Abstract: The invention provides a method of changing a ratio of 68 to 64 kDa protein of MRJP3 in a royal jelly, a method of producing a royal jelly comprising MRJP3 having a changed ratio of 68 to 64 kDa protein relative to a control royal jelly and the royal jelly produced thereform. Also provided is a method of promoting the growth of the larva of a queen bee comprising feeding the larva of the queen bee a royal jelly of the invention. Further provided is a method of producing bee larva, pupa and queen bees with sizes larger than normal.Type: ApplicationFiled: July 22, 2009Publication date: January 27, 2011Applicant: NATUREWISE BIOTECH & MEDICALS CORPORATIONInventors: Chung-Yang Huang, Chia-Nan Chen, Wei-Jung Chen, Wei-Jan Huang, Li-Ling Chi
-
Publication number: 20100322976Abstract: A mixture of honey (preferably manuka honey) with aloe vera extract is concentrated for distribution and then diluted before use as a tonic or food supplement for mammals, particular those with compromised or poorly performing immune systems. In particular (though without limit) the composition is useful in the control of chronic mastitis in dairy cows.Type: ApplicationFiled: February 5, 2008Publication date: December 23, 2010Inventor: Kuldeep Sharma
-
Publication number: 20100316728Abstract: A therapeutic mask includes a therapeutic composition including honey and a penetrating substance, a dressing having said therapeutic composition combined therewith, wherein the dressing and the therapeutic composition are freeze dried to provide the therapeutic mask. There is also a method of making and using the composition.Type: ApplicationFiled: June 15, 2009Publication date: December 16, 2010Inventors: William H. Rreeves, Jonathan W. Reeves, Alejandro Rendon, Marta J. Rendon
-
Publication number: 20100303742Abstract: Skin compositions comprising, hydrocortisone; allantoin; and a water-based vehicle that is essentially free of petroleum jelly, mineral oil and wax; and related method for protecting, healing and/or soothing the skin comprising: applying an effective amount of a cosmetic preparation selected from the group consisting of hand cream, foot cream, body cream, lip cream, lip gloss, lip stick, gel, balm and lotion to the skin surface; wherein said cosmetic preparation includes a skin composition made of hydrocortisone; allantoin; and a water-based vehicle that is essentially free of petroleum jelly, mineral oil and wax; and said effective amount is enough to protect, heal and/or soothe the skin surface.Type: ApplicationFiled: August 13, 2009Publication date: December 2, 2010Inventor: Norman Turkowitz
-
Publication number: 20100297205Abstract: This invention relates to a patch for the expulsion of insect poison from the skin after stings from membranous insects (Hymenoptera). The patch is characterized in comprising a poison-aspirating matrix comprising an expulsion agent as well as a swell layer, which swells after the addition of a liquid through a hole on the top of the patch and thus adds a light pressure to the poison-aspirating matrix towards the skin, whereby a local and relieving effect is achieved. In one embodiment, the matrix further comprises a local anesthetic. The expulsion agent is e.g. a carbohydrate. The swell layer consists e.g. of a silica gel.Type: ApplicationFiled: August 20, 2007Publication date: November 25, 2010Inventor: Martin Wenckens
-
Publication number: 20100291227Abstract: A lip lubricant for use as a lip coating during dental work, the lip lubricant comprising: one or more of a vegetable wax, a vegetable oil, a fruit wax, a fruit oil, a vegetable-based liquid wax ester, and a fruit-based liquid wax ester; and in which the lip lubricant has a room-temperature consistency that allows the lip lubricant to, in use, be applied to a user's lips by swab. A method of non-medically lubricating the lips of a user in preparation for dental work, the method comprising: spreading a lip lubricant onto the lips of the user, the lip lubricant comprising one or more of a vegetable wax, a vegetable oil, a fruit wax, a fruit oil, a vegetable-based liquid wax ester, and a fruit-based liquid wax ester; in which the lip lubricant has a room-temperature consistency that allows the lip lubricant to be applied by swab. In some embodiments the lip lubricants disclosed herein have a room-temperature consistency that prevents pouring.Type: ApplicationFiled: May 13, 2010Publication date: November 18, 2010Applicant: RMG HOLISTIC DENTAL PRODUCTS INC.Inventor: Ross M. Goodine
-
Publication number: 20100285147Abstract: Provided an acidic liquid preparation containing a herb and/or animal-origin extract at high concentration to suppress time-dependent occurrence of precipitation and/or opacity. A liquid preparation containing a herb-origin extract having pH of 3.0 to 5.5 and containing the herb-origin extract at a concentration of 5 to 50 w/v % (dry weight) to the total amount of the liquid preparation, containing a caramel at a concentration of 0.5 to 20 w/v % to the total amount of the liquid preparation, wherein the caramel has isoelectric point of 2.5 to 4.0 and 1.0 w/v % aqueous solution of the caramel has pH of 4.5 to 6.0. A liquid preparation containing an animal-origin extract having pH of 3.0 to 5.5 and containing the animal-origin extract at concentration of 5 to 50 w/v % (dry weight) to the total amount of the liquid preparation, containing a caramel at concentration of 0.5 to 20 w/v % to the total amount of the liquid preparation, wherein the caramel has isoelectric point of 0.5 to 4.0 and 1.Type: ApplicationFiled: July 31, 2008Publication date: November 11, 2010Applicant: WAKUNAGA PHARMACEUTICAL CO. LTDInventors: Soko Motoune, Mizuho Ono, Junichiro Wakamatsu, Shiho Kano, Yoichi Ikeda
-
Publication number: 20100247671Abstract: A method for increasing collateral circulation includes providing a pharmaceutically acceptable synthetic cerebrospinal fluid that has a density different than that of the patient's naturally-occurring cerebrospinal fluid. The synthetic cerebrospinal fluid includes a vasodilator. The method further includes administering the synthetic cerebrospinal fluid to an intrathecal space of a patient through a lumbar access point to reach the intrathecal space of a patient.Type: ApplicationFiled: March 26, 2009Publication date: September 30, 2010Inventor: Jeffrey E. Thomas
-
Publication number: 20100247670Abstract: Disclosed is a dry composition prepared from red grape by natural fermentation that is, once brewed, steeped within hot water, tasteful to ingest as herb tea, and that complementary contains antioxidants, Catechin, Resveratrol, Tannin, Quercetin bearing anti-inflammatory and blood glucose lowering capacities; as well as a human skin rejuvenating natural product derived there from.Type: ApplicationFiled: March 26, 2009Publication date: September 30, 2010Inventor: Dmitriy Shoutov
-
Publication number: 20100233285Abstract: A method of treating a respiratory disease in an animal, characterised by the step of administering a composition of a consistency that can be delivered to the respiratory system of the animal, wherein the composition contains a bio-active fraction of honey.Type: ApplicationFiled: December 14, 2007Publication date: September 16, 2010Applicant: WAIKATOLINK LIMITEDInventors: Mark Shane Stuart, Duncan George Mackintosh, Tania Leeanne Smith, Fiona Marie Miller
-
Publication number: 20100233284Abstract: Provided are a composition and method of increasing health of the human body includes placing a composition inside a solution jar of a solution jar assembly, wherein the composition comprises at least one of a garlic solution comprising garlic extract, ethanol, and water; a 10-undecenoic acid solution comprising 10-undecenoic acid and at least one of water and alcohol; and a Pau d'Arco solution comprising Pau d'Arco extract, corn starch, ethanol, and water, wherein the solution jar assembly includes a device comprising either a radial appliance or a wet-cell battery appliance; a first metal disc connected to the device by a first wire; a solution jar, connected to the device by a second wire, for holding the solution; a second metal disc connected to the solution jar by a third wire; and a connecting loop, located inside a removable lid of the solution jar, connecting the first and third wires and passing through the solution; wherein if the device is the radial appliance, placing the radial appliance in a coType: ApplicationFiled: March 13, 2009Publication date: September 16, 2010Inventor: Beth JOHN
-
Publication number: 20100233283Abstract: The present invention relates to medicinal compositions containing a honey having non peroxide antibacterial activity and wherein the composition comprises from about 19% to about 80% water by weight. The use of these compositions in the treatment of eye, respiratory and ear conditions is also disclosed.Type: ApplicationFiled: May 31, 2007Publication date: September 16, 2010Applicant: Medihoney Pty LtdInventor: Anthony Peter Moloney
-
Publication number: 20100215763Abstract: Alternative cellular energy pigments (ACE-pigments) are over-produced in response to various types of viral infections and to other pathological conditions. ACE pigments accumulate at the sites of disease and also in other regions of the body, including the oral cavity. ACE pigments are considered to play a significant role in the body's healing response to both local and system diseases. They appear to exist in a relatively inactive form in which they can fluorescence under ultraviolet (UV) light illumination, especially if stained with a suitable dye, such as neutral red. The present invention describes a method of using ACE pigments collected from the saliva (spittle) of patients for the purpose of activating the ACE pathway in a child with autism and in an adult with an active skin lesion caused by herpes simplex virus. The saliva containing the collected ACE pigments is placed onto a suitable material, such as a paper towel, stained with neutral red dye and induced to fluoresce using UV illumination.Type: ApplicationFiled: February 20, 2009Publication date: August 26, 2010Inventor: William John Martin
-
Publication number: 20100209527Abstract: The invention provides a composition for prevention or treatment of a disease associated with the production of an autoantibody. Specifically, it provides a composition for prevention or treatment of a disease associated with the production of an autoantibody, which comprises royal jelly as an active ingredient.Type: ApplicationFiled: July 23, 2008Publication date: August 19, 2010Inventors: Yoshiya Sato, Kaiisar Mannoor, Isao Shimabukuro, Kikuji Yamaguchi
-
Publication number: 20100196297Abstract: Alternative cellular energy pigments (ACE-pigments) are over-produced in response to various types of viral infections and to other pathological conditions. ACE pigments accumulate at the sites of disease and also in other regions of the body, including the oral cavity. ACE pigments are considered to play a significant role in the body's healing response to both local and system diseases. They appear to exist in a relatively inactive form in which they can fluorescence under ultraviolet (UV) light illumination, especially if stained with a suitable dye, such as neutral red. The present invention describes a method of using ACE pigments collected from the urine of patients for the purpose of activating the patient's ACE pathway in a child with autism, with an extrapolation to patients with a wide variety of other infectious and non-infectious illnesses for which there is a presumed or shown insufficiency of cellular energy.Type: ApplicationFiled: March 5, 2009Publication date: August 5, 2010Inventor: William John Martin
-
Patent number: 7767195Abstract: A high throughput neurophysiological assay for identifying anti-psychotic compounds is disclosed. In particular, a high throughput neurophysiological assay using information obtained from injecting a neural activity blocker, such as tetrodotoxin (TTX), into one hippocampus persistently coactivated pyramidal cells in the uninjected hippocampus that initially discharged independently. In accord with the definition of cognitive disorganization, pyramidal cell firing rates only changed for 15 min and did not accompany the coactivation. The disclosed assay uses the TTX-induced coactivity of hippocampal pyramidal cell discharge to identify compounds that may prevent or attenuate the changes in the hippocampal pyramidal cell discharge observed when a neural activity blocker is administered. The assays of the invention are useful for high throughput screening of targets in the discovery of drugs that have anti-psychotic properties.Type: GrantFiled: May 8, 2007Date of Patent: August 3, 2010Assignee: The Research Foundation of State University of New YorkInventor: Andre A. Fenton
-
Publication number: 20100189675Abstract: The present invention relates to the cosmetic use of at least one imidopercarboxylic acid derivative in a cosmetic composition comprising a physiologically acceptable medium, as agent for promoting desquamation of the skin and/or the scalp and/or for stimulating epidermal renewal, the associated method of cosmetic treatment and a composition comprising the said imidopercarboxylic acid derivative and a desquamating agent and/or an anti-ageing agent.Type: ApplicationFiled: June 24, 2008Publication date: July 29, 2010Applicant: L'OrealInventor: Pascale Pelletier
-
Publication number: 20100189670Abstract: Methods are provided for enhancing the longevity of the binding of various benefit agents to hair and skin. Applications of traditional and non-traditional colorants and conditioners to hair and skin are amended with compositions of hair or skin-binding peptides respectively. The presence of the hair or skin-binding peptide compositions act to increase the longevity of the applied colorant or conditioner on the hair or skin.Type: ApplicationFiled: April 6, 2010Publication date: July 29, 2010Applicant: E.I. DU PONT DE NEMOURS AND COMPANYInventors: WILLIAM A. BECK, JOHN P. O'BRIEN, HONG WANG
-
Publication number: 20100173007Abstract: A topical composition for treating skin diseases is provided. The composition comprises calendula, tea tree oil, eucalyptus oil, grape seed oil, and Aloe Vera. In some embodiment, the composition may also include beeswax, vegetable oil, vitamin E, rosemary oil, or shea butter or combinations thereof to further enhance its beneficial effects.Type: ApplicationFiled: March 17, 2010Publication date: July 8, 2010Inventor: Rose Marie DiLeva
-
Publication number: 20100159024Abstract: A method and apparatus are provided for the extraction and collection of coelomic fluid of sea stars. The method includes feeding sea stars, one at a time, from storage into the mouth of a longitudinally-moving gripper. The method includes moving the sea stars in a downstream direction by means of the longitudinally-moving gripper. The method includes severing the tip of the arm of the sea star. The method includes allowing the coelomic fluid to drain out of the severed arm of the sea star; The method includes accumulating the drained coelomic fluid. The method includes collecting the accumulated drained coelomic fluid. Finally, the method includes discharging the sea stars from the longitudinally-moving gripper.Type: ApplicationFiled: November 10, 2009Publication date: June 24, 2010Inventors: Richard Ablett, Mike McKenna, Stephen McKenna, Kevin Sibley